Shanghai Shen Lian Biomedical Corporation (SHA:688098)

China flag China · Delayed Price · Currency is CNY
8.37
+0.05 (0.60%)
Aug 4, 2026, 3:00 PM CST
Market Cap3.41B -1.4%
Revenue (ttm)272.12M -7.5%
Net Income-19.21M
EPS-0.05
Shares Out 407.23M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,432,779
Open8.31
Previous Close8.32
Day's Range8.31 - 8.50
52-Week Range7.29 - 17.57
Beta0.55
Analystsn/a
Price Targetn/a
Earnings DateAug 31, 2026

About SHA:688098

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. The company offers swine vaccines, ruminant vaccine, diagnostic reagents, and pet biological products. It also provides monoclonal antibody drug for HIV treatment, anti-allergy anti-IgE monoclonal antibody drug, and anti-herpes simplex virus monoclonal antibody drugs. In addition, the company offers foot-and-mouth disease vaccines for pigs, cattle, and sheep; and porcine circovirus type 2 subunit vacci... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 375
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688098
Full Company Profile

Financial Performance

In 2025, SHA:688098's revenue was 288.27 million, a decrease of -4.99% compared to the previous year's 303.41 million. Losses were -20.50 million, -54.19% less than in 2024.

Financial Statements